• InterView
• “Olumiant provides rapid AD symptom improvement"
• by jung, sae-im Aug 6, 2021 06:04am

• Policy
• Last year, the drug trade surplus was achieved
• by Lee, Tak-Sun Aug 5, 2021 08:47pm

• Company
• Generic share in the Tamsulosin market has surpassed 60%
• by Kim, Jin-Gu Aug 5, 2021 08:46pm

• Company
• Keytruda's sales in Q1 of the year are ₩9 trillion
• by Aug 5, 2021 08:46pm

• Company
• Sales of PPI antiulcer agents rise 30% in 2 years
• by An, Kyung-Jin Aug 5, 2021 06:03am

• Product
• "Inhibiting ANO1 activity has effect on treating psoriasis"
• by Lee, Jeong-Hwan Aug 5, 2021 06:02am

• Company
• Restylane Kysse has been approved in Korea
• by jung, sae-im Aug 5, 2021 12:41am

• Company
• Roche’s Polivy can be prescribed at general hospitals
• by Eo, Yun-Ho Aug 5, 2021 12:40am

• Policy
• No prior approval req. filed for Soliris, 47 for Ultomiris
• by Lee, Hye-Kyung Aug 4, 2021 06:01am

• Policy
• Will changes be made to Hemlibra’s reimbursement standards?
• by Lee, Jeong-Hwan Aug 4, 2021 06:01am